Initial viral load in cases of single human papillomavirus 16 or 52 persistent infection is associated with progression of later cytopathological findings in the uterine cervix
暂无分享,去创建一个
K. Yoshiura | H. Masuzaki | A. Kinoshita | K. Miura | S. Abe | S. Miura | K. Yamasaki | D. Hamaguchi
[1] K. Kapila,et al. Viral load of human papillomavirus in women with normal and abnormal cervical cytology in Kuwait. , 2013, Journal of infection in developing countries.
[2] D. Olive,et al. Two years outcome of women infected with high risk HPV having normal colposcopy following low‐grade or equivocal cytological abnormalities: Are HPV16 and 18 viral load clinically useful predictive markers? , 2012, Journal of medical virology.
[3] M. Sherman,et al. Human Papillomavirus Load Measured by Linear Array Correlates with Quantitative PCR in Cervical Cytology Specimens , 2012, Journal of Clinical Microbiology.
[4] K. Yoshiura,et al. Pre‐vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology , 2011, The journal of obstetrics and gynaecology research.
[5] D. Celentano,et al. Kinetics of DNA load predict HPV 16 viral clearance. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[6] M. Inoue,et al. Adoption of HPV testing as an adjunct to conventional cytology in cervical cancer screening in Japan , 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[7] A. Botezatu,et al. The relationship between HPV16 and HPV18 viral load and cervical lesions progression. , 2009, Roumanian archives of microbiology and immunology.
[8] C. Wheeler,et al. Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. , 2009, Journal of the National Cancer Institute.
[9] H. Masuzaki,et al. Genital human papilloma virus infection in mentally-institutionalized virgins. , 2007, Gynecologic oncology.
[10] S. Franceschi,et al. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.
[11] T. Sano,et al. Quantitative real-time polymerase chain reaction analysis of the type distribution, viral load, and physical status of human papillomavirus in liquid-based cytology samples from cervical lesions , 2007, International Journal of Gynecologic Cancer.
[12] H. Richet,et al. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy , 2006, Journal of medical virology.
[13] N. Lalaoui,et al. Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] T. Cheung,et al. Quantitative analysis of human papillomavirus type 16 in cervical neoplasm: a study in Chinese population. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[15] U. Gyllensten,et al. High viral loads of human papillomavirus predict risk of invasive cervical carcinoma , 2005, British Journal of Cancer.
[16] K. Kariya,et al. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. , 2004, The Journal of infectious diseases.
[17] J. Sautière,et al. Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort study , 2003, International journal of cancer.
[18] U. Gyllensten,et al. Real-Time PCR-Based System for Simultaneous Quantification of Human Papillomavirus Types Associated with High Risk of Cervical Cancer , 2003, Journal of Clinical Microbiology.
[19] M. Sherman,et al. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[20] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[21] A. Berger,et al. Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. , 2002, The Journal of antimicrobial chemotherapy.
[22] P. Snijders,et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance , 2002, International journal of cancer.
[23] S. Nieh,et al. Viral load of high‐risk human papillomavirus in cervical squamous intraepithelial lesions , 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[24] T. Rohan,et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. , 2001, JAMA.
[25] A. Moscicki,et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. , 2001, JAMA.
[26] C. Woodman,et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study , 2001, The Lancet.
[27] H. Adami,et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.
[28] H. Adami,et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study , 2000, The Lancet.
[29] David R. Scott,et al. Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.
[30] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[31] L Beardsley,et al. Natural history of cervicovaginal papillomavirus infection in young women. , 1998, The New England journal of medicine.
[32] G. Schoolnik,et al. Variability of Human Papillomavirus DNA Testing in a Longitudinal Cohort of Young Women , 1993, Obstetrics and gynecology.
[33] Cdm Fletcher,et al. World Health Organization Classification of Tumours , 2002 .
[34] J. Higginson. International Agency for Research on Cancer. , 1968, WHO chronicle.